ALDX icon

Aldeyra Therapeutics

66 hedge funds and large institutions have $96.4M invested in Aldeyra Therapeutics in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

25% more capital invested

Capital invested by funds: $77.1M → $96.4M (+$19.3M)

6.53% more ownership

Funds ownership: 53.79%60.33% (+6.5%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$42K
Puts
$3K
Net Calls
Net Calls Change

Top Sellers

1 -$1.29M
2 -$331K
3 -$224K
4
ECM
Element Capital Management
New York
-$123K
5
Goldman Sachs
Goldman Sachs
New York
-$117K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$312K
27
$270K
28
$243K
29
$237K
30
$207K
31
$194K
32
$194K
33
$184K
34
$170K
35
$154K
36
$154K
37
$140K
38
$135K
39
$133K
40
$113K
41
$110K
42
$104K
43
$91K
44
$85K
45
$83K
46
$82K
47
$79K
48
$57K
49
$37K
50
$24K